Product Information
HYDROMORPHONE HCL ER 8 MG TAB is a generic product labeled by Camber Pharmaceuticals Inc., priced at $5.8345 per EA under NDC 31722011901. Its NADAC has been published 166 times since Jun 21, 2023.
FDA first approved this application on Sep 23, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
8 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722011901
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
HYDROMORPHONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212133FDA Approved
9/23/2020
TE Code
AB
On Market Since
9/24/2020
Pharmacological Classes
Price Statistics
The NADAC for HYDROMORPHONE HCL ER 8 MG TAB has been published 166 times since Jun 21, 2023, and over the history we have for it it has risen 78.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.8345 per EA |
|---|---|
| All-time high | $7.0165 (Apr 15, 2026) |
| All-time low | $3.0250 (Mar 20, 2024) |
| 52-week high | $7.0165 |
| 52-week low | $5.8345 |
| Median price | $4.7714 |
| Average price | $4.8785 |
| Largest weekly change | +45.8% (Oct 18, 2023) |
| Weeks tracked | 166 |
| Tracking since | Jun 21, 2023 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 90% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of HYDROMORPHONE HCL ER 8 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for HYDROMORPHONE HCL ER 8 MG TAB, manufactured by Camber Pharmaceuticals Inc., is $5.8345 per EA (NDC 31722011901), effective Aug 19, 2026.
How has the price of HYDROMORPHONE HCL ER 8 MG TAB changed over time?
Over the history we have for it, the NADAC for HYDROMORPHONE HCL ER 8 MG TAB has risen 78.3%. It has been tracked across 166 weekly CMS publications since Jun 21, 2023.
What are the highest and lowest recorded NADAC prices for HYDROMORPHONE HCL ER 8 MG TAB?
Since Jun 21, 2023, the NADAC for HYDROMORPHONE HCL ER 8 MG TAB has ranged from a low of $3.0250 (Mar 20, 2024) to a high of $7.0165 (Apr 15, 2026), with a median of $4.7714 per EA.
Are there cheaper alternatives to HYDROMORPHONE HCL ER 8 MG TAB?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HYDROMORPHONE 8 MG TABLET, is $0.5683 per EA — about 90% below HYDROMORPHONE HCL ER 8 MG TAB.
Who manufactures HYDROMORPHONE HCL ER 8 MG TAB?
HYDROMORPHONE HCL ER 8 MG TAB (NDC 31722011901) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.